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Purpose: The aim of this study was to investigate the effects of an ophthalmic gel containing 
sodium hyaluronate and xanthan gum in addition to the antibiotic netilmicin in the management 
of traumatic corneal abrasions.
Patients and methods: Patients with traumatic corneal abrasions were randomly treated as 
follows: Group A (n = 20) with an occlusive patching for 12 hours plus one drop of an eye gel 
containing 0.15% sodium hyaluronate, 1% xanthan gum and 0.3% netilmicin qid for 5 days; 
and Group B (n = 20) with an occlusive patching for 2–3 days plus one application of 0.3% 
netilmicin ophthalmic ointment qid for 5 days. All patients were evaluated after the third and 
seventh day by slit-lamp examination, fluorescein staining, and corneal defect photograph in 
order to assess corneal re-epithelialization. Conjunctival hyperaemia, lid oedema, subjective 
symptoms of discomfort, and conjunctival swabs were also evaluated.
Results: No statistically significant difference was observed between the groups in terms of 
the extent of corneal healing after 3 days of treatment. Both treatments were also highly effec-
tive in decreasing the erosion score and the conjunctival hyperemia (P , 0.0001, P , 0.005, 
respectively) without any significant difference between the two types of treatment. Subjective 
symptoms of discomfort and conjunctival swabs were also evaluated.
Conclusion: In the management of traumatic corneal abrasions, the administration of an eye 
gel containing sodium hyaluronate and xanthan gum is able to reduce the length of occlusive 
patching. In addition, the presence of netilmicin guarantees good antibiotic prophylaxis during 
the wound repair process.
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Corneal abrasion is a defect of the corneal epithelial surface, accounting for approxi-
mately 10% of the visits to eye emergency units. It is characterized by acute ocular 
pain and other symptoms of discomfort affecting the quality of life of patients.1 Simple 
corneal abrasions rarely become complicated, and in most cases a complete recovery 
occurs in few days.
An abundance of literature suggests different regimens of corneal abrasion 
treatment.2–8 Thus, treatment is mostly by individual choice. Eye patching is perhaps 
the most controversial issue in the treatment of corneal abrasions.4–8 However, a 
recent survey indicated that, even in absence of reproducible scientific evidence, this 
procedure remains the mainstay of corneal abrasion management in combination with 
topical antibiotic, cycloplegic, and oral analgesics.2
The aim of our study was to investigate the possibility of reducing the length of 
patching by using an eye gel that is able to both promote wound healing and prevent 
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  ocular infections. This gel has no preservative and con-
tains two natural biopolymers (xanthan gum and sodium 
hyaluronate) in addition to netilmicin. Hyaluronate is well 
known for promoting physiological wound healing by stimu-
lating corneal epithelial cell migration and proliferation,9–11 
whereas netilmicin is an effective, safe, and noncytotoxic 
antibiotic that is able to provide good protection against bacte-
rial infections during the process of wound repair.12–15
Material and methods
Patients
Our study enrolled 40 consecutive patients with a traumatic 
or foreign body removal-related corneal abrasion   (occurring 
within 24 hours of the beginning of the study and not caused 
by thermal, radiant, or caustic agents) that spared the   Bowman 
membrane and the limbus, and involved ,50% of the cornea 
and with corneal fluorescein uptake. The patients were of 
either sex and aged between 18 and 55 years. Patients were 
randomly assigned to two treatment groups with different 
lengths of time of patching. The first group (n = 20) dressed 
an occlusive patch (Eycopad®; Hartmann AG, Heidenheim, 
Germany) for only 12 hours and received one application of 
an eye gel containing 0.15% sodium hyaluronate, 1% xanthan 
gum, and 0.3% netilmicin (Xanternet; SIFI SpA, Catania, 
Italy) qid for 5 days. The second group (n = 20) dressed the 
same occlusive patch for 3 days. In this group, the antibi-
otic prophylaxis was ensured by the use of 0.3% netilmicin 
ophthalmic ointment (Nettavisc; Eyelab SrL, Milan, Italy) 
qid for 5 days. The protocol was approved by the local ethics 
committee, and all patients gave written informed consent 
according to the Declaration of Helsinki.
Evaluation
All patients were evaluated three times in a period of 7 days 
(Day 1, Day 3, and Day 7). During the enrolment visit (Day 1), 
patients were subjected to a slit lamp (SL990 digital, CSO Srl, 
Florence, Italy) examination of both eyes. A slit-lamp exami-
nation was also performed on the fellow (non-injured) eye to 
ensure the absence of corneal dystrophies or other corneal 
pathology. In case of eligibility, patients started the assigned 
treatment. Before starting treatment, corneal defects were 
stained with fluorescein and photographed by a digital camera 
connected to the slit lamp microscope (CSO Srl, Firenze, 
Italy). The total surface area of the epithelial defect (mm2) was 
measured (Figure 1) using Epsilon Lyrae software (Version 
1.0, CSO Srl, Florence, Italy). The extent of punctate erosions 
was evaluated according to the National Eye Institute/Industry 
Workshop system.16 A standardized grading system (0 = none, 
Figure 1 Measurement of epithelial defect.
Notes: Epithelial defects were stained with fluorescein (green) and photographed 
by a digital camera connected to the slit lamp microscope. The surface area of the 
defect (red area) was measured (mm2) by using Epsilon Lyrae software (Version 1.0, 
CSO Srl, Florence, Italy).
1 = trace, 2 = mild, 3 = moderate, 4 = severe) was used for each 
of the five areas of the cornea and a summary score was then 
calculated. At Day 3 ± 1 and Day 7 ± 1, slit lamp examination, 
corneal fluorescein staining, and photograph were repeated. 
A unique independent operator was involved in the evalua-
tion of corneal re-epithelialization in a blind manner. At all 
visits, the degree of conjunctival hyperaemia and lid edema 
were evaluated by using a categorical grading scale (0 = none, 
1 = mild, 2 = moderate, 3 = severe). Subjective symptoms of 
ocular discomfort (pain, foreign body sensation, tearing, and 
photophobia) were also   evaluated by a visual analogue rat-
ing scale (VARS).   Conjunctival swabs (BD CultureSwab™; 
Becton Dickinson and Company, Sparks, MD, USA) were 
also performed at Day 1 and Day 7 ± 1 to rule out bacterial 
ocular infections.
Statistics
Statistical analysis was performed by a qualified statistician 
(DS) using the SAS software (version 9.1, SAS Institute 
Inc, Cary, NC). All statistical tests were two-sided, with 
a 5% significance level and were regarded as descriptive 
only, according to the exploratory nature of the study. The 
primary clinical parameter considered in the study was the 
extent of corneal reepithelialization at Day 3 ± 1. The total 
surface area of the epithelial defect was measured (mm2) 
and compared within and between each treatment group, 
by a Wilcoxon test for paired or independent observa-
tions, respectively. The extent of corneal punctate erosions 
(erosion score), the degree of conjunctival hyperemia, lid 
edema, and the evaluation of subjective symptoms of ocular 
discomfort were also evaluated by a Wilcoxon signed rank,   
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considering assessments at Day 1 as baseline evaluation. The 
percentage of patients with ocular infections was compared 
between the 2 groups using Fisher’s exact test. The primary 
population for analyzing the performance included subjects 
who were visited and received treatments for 3 ± 1 days (full 
analysis data set). Safety analysis was done on all patients 
who received at least one dose of the treatment.
Results
The demographic characteristics of all randomized patients 
are displayed in Table 1; no significant differences were 
observed between the 2 treatment groups. Four patients (two 
in each group) did not complete the study because of lack of 
follow up, and therefore the efficacy analysis was performed 
on 36 patients.
The area of the lesion (Figure 2) at the beginning of the 
study was 2.56 ± 2.80 mm2 in the group treated with the eye 
gel and 1.75 ± 2.06 mm2 in the control group (full analysis 
data set). After 3 days, both treatments were highly effec-
tive in decreasing the total surface area of the epithelial 
defect (0.07 ± 0.27 versus 0.04 ± 0.07 mm2, respectively: 
P , 0.0001, Wilcoxon signed rank test), whereas no statisti-
cally significant differences were observed between the two 
treatment groups (P = 0.367).
With regard to the corneal reepithelialization, both treat-
ments were highly effective in decreasing the erosion score 
and the conjunctival hyperemia (P , 0.0001 and P , 0.005, 
respectively: Wilcoxon signed rank test; Table 2). No dif-
ferences were observed between the 2 treatment groups 
(P = 0.752 and P = 0.888 for erosion score and conjunctival 
hyperemia, respectively).
Finally, all symptoms of ocular discomfort (pain, foreign 
body sensation, tearing, and photophobia) decreased to the 
same extent in a clinically significant way within each group 
with no differences between the patched and the nonpatched 
group (data not shown).
Ocular infections were detected in only 2 patients (6%), 
and in both cases, the isolated bacteria were fully eradicated 
at the follow-up visit.
No patient experienced adverse events during the 
study.
Discussion
Minor trauma to the ocular surface can cause corneal 
  abrasion. This is a commonly presented eye complaint 
characterized by pain, foreign body sensation,   photophobia, 
and transient decrease in visual acuity. Classically, the 
standard of care for treatment of corneal abrasion has been 
the use of a pressure eye patch with topical antibiotic and 
mydriatics for 24–48 hours.4,8 These procedures remain 
largely prescribed although there is no strong evidence for 
their use.4,8,17–19 The indication for eye patch use is particu-
larly controversial because it reduces corneal oxygenation 
and increases corneal temperature, which result in a higher 
chance of infection.2,3,6 In addition, the loss of binocular 
vision can cause a reduction in visual field and depth per-
ception. Accordingly, recent Cochrane database systematic 
reviews on patching for corneal abrasion concluded that 
patching is not recommended for lesions smaller than 
10 mm2.5 Other means of managing corneal abrasion have 
also been proposed, such as soft bandage contact lenses, 
which have been demonstrated to be better than patching 
in reducing ocular pain and promoting wound healing in 
large surface areas (.4 mm). However, there were concerns 
over their infection rates, costs, and need for follow up.20 
Table 1 Demographics (all randomized patients)
Short patching  
plus eye gel
Regular  
patching
Total
number of patients 20 20 40
gender (number,%)
  Male 17 (85%) 19 (95%) 36 (90%)
  Female 3 (15%) 1 (5%) 4 (10%)
Age (years)
  Mean 38 37 37
  SD 7.60 9.68 8.59
  Range 22–54 23–55 22–55
Area of the epithelial defect (mm2)
  Mean 2.55 1.73 2.14
  SD 2.65 1.95 2.34
  Range 0.38–9.67 0.34–7.98 0.34–9.67
Abbreviation: SD, standard deviation.
Day 3
12 hrs patching + eye gel 
3 days patching
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Figure 2 Effect on corneal reepithelialisation.
Notes:  Corneal  defect  was  stained  with  fluorescein  and  photographed  before 
starting treatment (day 1) and after 3 days. The total surface area of the epithelial 
defect (mm2) was measured by using Epsilon Lyrae software (Version 1.0, CSO Srl, 
Florence, Italy). Data (full analysis data set) are expressed as mean ± SD. *P , 0.0001, 
Wilcoxon signed rank test (within groups).
Abbreviation: SD, standard deviation.
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Collagen shields have also proven to be more comfortable 
than patching, but they are not used in clinical practice.21 
Nevertheless, the most recently published survey on cor-
neal abrasion management conducted in an accident and 
emergency department in the UK has confirmed that eye 
patching is still widely used in clinical practice.2
During the wound repair process, the use of a lubricant is 
always advisable because hydration and lubrication smooth 
out irregularities in the corneal epithelium, thus protecting the 
ocular surface from damage due to friction and   desiccation. 
For this reason, we evaluated the effect of a lubricant eye gel 
in patients with corneal abrasion sparing the Bowman mem-
brane and involving less than 50% of the cornea. This gel is 
available in some EU countries (Xanternet) in preservative-
free unidoses containing two natural biopolymers, sodium 
hyaluronate and xanthan gum, in addition to aminoglycoside 
netilmicin. Sodium hyaluronate and xanthan gum are high 
molecular weight polysaccharides with water binding and 
mucoadhesivity properties, providing effective hydration and 
protection of the cornea.22–26 In addition, sodium hyaluronate is 
well known to promote wound healing by stimulating corneal 
epithelial cell migration and proliferation.9–11 Netilmicin is a 
broad spectrum, third generation aminoglycoside with excel-
lent in vitro activity against the most common bacterial ocular 
pathogens, including Pseudomonas spp.14,27–29 Netilmicin is 
noncytotoxic and does not interfere with physiological heal-
ing, and is therefore able to provide good protection against 
bacterial infections during the wound repair process.12,13,15
Conclusion
In the present study, we compared “routine” patching (48 to 
72 hours) with short patching (12 hours), followed by a treat-
ment with the eye gel in patients with simple corneal erosion. 
Corneal defects were photographed, stained with fluorescein, 
and measured at each control visit, allowing an objective 
evaluation of the wound healing. Other parameters, such 
as the extent of punctate erosions, conjunctival, hyperemia, 
lid edema, pain, and other subjective symptoms of ocular 
discomfort, were also evaluated throughout the study. After 
3 days, the residual corneal defect and all other parameters 
were not statistically different.
The major limitation of the study is the trial design; the two 
groups of patients were not fully comparable because of the 
different uses of the patching regime. In addition, an evaluation 
of wound healing earlier than 3 days was missed. Nevertheless, 
our data suggest that although a reduction of the duration of 
patching followed by the topical administration of Xanternet 
eye gel does not affect the healing of the corneal defect, it does 
improve patient compliance. Additional clinical data with more 
patients comparing a group treated with the eye gel with a non-
patched group are required to recommend the eye gel as unique 
tool in the management of traumatic corneal abrasions.
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